Executive Movement:
Flagship Pioneering recruits former BMS, Celgene R&D chief Rupert Vessey (PR)
Voyager Therapeutics, Inc. Therapeutics Announces Appointment of Jacquelyn Fahey Sandell as Chief Legal Officer (PR)
ReCode Therapeutics Appoints Erica Jefferson as Senior Vice President of Corporate Affairs (PR)
Alloy Therapeutics, Inc., appoints Mike Schmidt, PhD as its Chief Scientific Officer and promotes Martin Leach, PhD MBA, PhD, MBA to Chief Operating Officer (PR)
Replicate Bioscience, Inc. Bioscience Appoints Rachael Lester as Chief Business Officer (PR)
Nkarta, Inc. Appoints Alyssa Levin as Chief Financial and Business Officer (PR)
Lyell Immunopharma Appoints Matthew Lang as Chief Business Officer (PR)
Verismo Therapeutics Welcomes Dr. Mala Talekar as Vice President of Clinical Development (PR)
Akamis Bio has appointed Oliver Rosen, M.D., to be the oncology company’s chief medical officer, Peter Kosa, Ph.D., as chief business officer and Samantha Bailey-Bucktrout, Ph.D., as SVP and head of research (PR)
Vir Biotechnology, Inc. Appoints Sasha Damouni Ellis as Executive Vice President and Chief Corporate Affairs Officer (PR)
Garuda Therapeutics Announces the Appointment of Giorgia Scapin, Ph.D., as Chief Scientific Officer (PR)
Ultragenyx Appoints Howard Horn as Chief Financial Officer and Executive Vice President, Corporate Strategy (PR)
TScan Therapeutics Announces Transition of Chief Financial Officer (PR)SonoThera™ Expands Leadership Team Appointing Carolyne Zimmermann as Chief Business Officer (PR)
EDIRNA unveiled its leadership team, with Christopher W. Kennedy as CEO steering the ship(PR)
Board Placements:
Normunity appoints industry leader Debanjan Ray to Board of Directors (PR)
Switch Therapeutics Appoints Douglas Fambrough, Ph.D., to Board of Directors (PR)
Eterna Therapeutics Appoints Biotech Industry Veterans Brant Binder and Richard Wagner, Ph.D. to Board of Directors (PR)
Irena Melnikova Joins Crossbow Therapeutics, Inc Therapeutics Board of Directors after $80M Series A
Global Blood Therapeutics Appoints Ted Love W. Love, M.D., to the Company's Board of Directors (fiercebiotech)
